Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Onglyza (saxagliptin), a new treatment for type 2 diabetes mellitus in adults, now available in u.s. pharmacies
AstraZeneca, 08/17/09
Bristol–Myers Squibb Company and AstraZeneca announced that ONGLYZA, a dipeptidyl peptidase–4 inhibitor, approved by the U.S. Food and Drug Administration on July 2009, is now available, by prescription, in pharmacies across the United States. Bristol–Myers Squibb and AstraZeneca began shipping ONGLYZA to wholesalers the next business day following the FDA approval.
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
A Multicenter, Double-Blind, Randomized, Parallel Group Study Comparing Polyvinyl Chloride and Polyvinyl Chloride-Free Catheter Materials
The Journal of Urology, 11/24/09
Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
Anticancer Research, 11/16/09
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkins Lymphoma
Cephalon, 11/06/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization
Current Medical Research and Opinion, 11/25/09
Anti-relapse medications: Preclinical models for drug addiction treatment
Pharmacology & Therapeutics, 11/25/09
Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/25/09
Today in Pharmacy Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients
Current Medical Research and Opinion, 11/17/09
Effect of a weight-based prescribing method within an electronic health record on prescribing errors
American Journal of Health-System Pharmacy, 11/10/09
Analysis of the impact and burden of illness of adult chronic ITP in the US
Current Medical Research and Opinion, 11/06/09
Sponsor
Article Search
Sponsor


See Latest Articles


